Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by I De la Torre
THU0088 Structural Damage Progression in Patients Treated With Methotrexate, Baricitinib Monotherapy or Baricitinib + Methotrexate Based on Their Level of Clinical Response in the Phase 3 Ra-Begin Study
Related publications
SAT0058 Effects of Baricitinib on Patients Who Stop Methotrexate Monotherapy and Switch to Baricitinib Monotherapy
Long-Term Work Productivity Improvement From Phase 3 Baricitinib Ra-Beam Study: Latin American Subgroup Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efficacy of Tofacitinib Monotherapy in Methotrexate-Naive Patients With Early or Established Rheumatoid Arthritis
RMD Open
Rheumatology
Allergy
Immunology
Mean Cost Per Number Needed to Treat With Tocilizumab Plus Methotrexate Versus Abatacept Plus Methotrexate in the Treatment of Rheumatoid Arthritis in Patients Previously Treated With Methotrexate
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Improvements in Clinical Response Between 12 and 24 Weeks in Patients With Rheumatoid Arthritis on Etanercept Therapy With or Without Methotrexate
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Pms5 - A Network Meta-Analysis to Evaluate the Efficacy of Baricitinib and Other Treatments of Rheumatoid Arthritis in Patients Who Are Inadequate Responders to Methotrexate
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Letter: Addition of Methotrexate Neither Restores Clinical Response Nor Improves the Pharmacokinetic Profile of Vedolizumab-Treated Patients
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic and Safety Outcomes From the 24-Month Phase 3 ORAL Scan Study
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Achieving Comprehensive Disease Control in Patients With Early and Established Rheumatoid Arthritis Treated With Adalimumab Plus Methotrexate Versus Methotrexate Alone
RMD Open
Rheumatology
Allergy
Immunology